Earnings Call for Q1FY22 of Suven Pharmaceuticals
Conference Call with Suven Pharmaceuticals Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.16-08-2021
16-08-2021
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Financial Results of the Company for the quarter ended June 30, 2021. The advertisements as appeared on August 14, 2021 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements16-08-2021
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed Investor Presentation16-08-2021
Q1FY22 Result Announced for Suven Pharmaceuticals Ltd.
Hightlights: The Company is focused on the business of Contract Development and Manufacturing Operations (CDMO). The consolidated financials include the results of the wholly owned subsidiary Suven Pharma, Inc., and associate Rising Pharma Holdings, Inc., USA. The Board has allotted the Bonus shares at 1:1 ratio in its Board meeting held on 29 September’ 2020. Accordingly, the number of shares increased from 12,72,82,478 to 25,45,64,956. In order to maintain uniformity and comparability the EPS of previous period have been restated. The COVID-19 continuous to impact the business and research operations in India, like increase in some of the raw material costs, non-availability of vessels leading to delay in shipments and increase in transportation costs. However, there was no major impact on our wholly owned subsidiary, Suven pharma, Inc., USA. Result PDF13-08-2021
Suven Pharmaceuticals Ltd - 543064 - Un-Audited Standalone And Consolidated Financial Results Prepared Under Ind AS Along With Limited Review Reports Of The Statutory Auditors For The Quarter Ended 30Th June, 2021
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. August 13, 2021, has taken on record and approved the Un-audited Standalone and Consolidated Financial Results prepared under Ind AS along with Limited Review Reports of the Statutory Auditors for the quarter ended 30th June, 2021. We are enclosing herewith the following documents: 1) Un-audited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2021 2) Limited Review Reports on the financial results as mentioned above and 3) A copy of the News Release of our company We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:50 P.M.13-08-2021
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Monday, August 16, 2021 at 10:00 a.m. IST to discuss the Un-audited Financial Results for the Q1FY22, to be declared on August 13, 2021.09-08-2021
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated August 6, 2021 regarding Notice of the 3rd AGM, please find enclosed the copies of the newspaper advertisements regarding to Notice of the 3rd Annual General Meeting of the Company and E-Voting Information. The advertisements as appeared today i.e. August 7, 2021 in Nava Telangana (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements07-08-2021
Suven Pharmaceuticals Ltd - 543064 - Reg. 34 (1) Annual Report
With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice convening the 3rd AGM of the Members of the Company and the Annual Report for the fiscal 2021 which is simultaneously circulated to the shareholders through electronic mode. The 3rd AGM will be held on Tuesday, August 31, 2021 at 11:30 a.m. IST through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: https://www.suvenpharm.com/index.php/investors/financial-info/annual-reports.06-08-2021
Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Friday, The 13Th August, 2021
Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Friday, the 13th August, 2021 at 11:30 a.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ending June 30, 2021 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st July, 2021 as per PIT Code of the Company. Trading window will be opened from 17th August, 2021.06-08-2021
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding the 3rd Annual General Meeting to be held through Video Conferencing (VC)/ Other Audio Visual Means (OVAM), record date and final dividend information'. The advertisements as appeared today i.e. August 3, 2021 in Nava Telangana (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements03-08-2021